Compounded Tirzepatide Dosage Calculator
Compounded tirzepatide dosage calculator helps patients and providers determine precise injection units based on prescribed dose and vial concentration. As compounded tirzepatide grows in popularity (2026), correct dosing ensures safety and efficacy. This tool integrates the latest titration protocols, concentration conversions, and a complete week-by-week escalation guide for US-based adults using compounded tirzepatide under medical supervision.
Custom dosing calculator
Always verify final dose with your prescribing physician. Compounded medications may vary in potency; use only as directed.
Standard tirzepatide titration schedule (2026)
| Treatment weeks | Weekly dose (mg) | Clinical notes |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Initiation / loading phase |
| Weeks 5–8 | 5 mg | First therapeutic escalation |
| Weeks 9–12 | 7.5 mg | Optional if needed for glycemic/weight goals |
| Weeks 13–16 | 10 mg | Standard maintenance step |
| Weeks 17–20 | 12.5 mg | For resistant cases |
| Week 21+ | 15 mg (max) | Maximum studied dose in SURMOUNT trials |
How to use the compounded tirzepatide dosage calculator
Our tirzepatide compound dosage calculator solves a common challenge: converting weekly milligrams (mg) into measurable insulin units. Many compounded pharmacies provide vials with different strengths (5 mg/mL, 10 mg/mL, 20 mg/mL). By entering your exact prescribed dose and the vial’s concentration, you instantly get the number of units to draw into an insulin syringe. For example: a 5 mg weekly dose using a 10 mg/mL vial requires 0.5 mL = 50 units. This ensures precision and reduces dosing errors.
Exclusive insight: why 2026 compounded protocols differ
Unlike brand Mounjaro® pens (fixed doses), compounded tirzepatide allows flexible titration, but also increases risk if misdosed. In 2026, major US compounding pharmacies follow USP <797> guidelines, and many offer concentrations like 8 mg/mL or 12.5 mg/mL. Our calculator adapts to any custom concentration. Additionally, recent FDA shortage updates (2025–2026) have expanded access to 503B facilities, making accurate unit conversion more critical than ever. We recommend storing the vial at 36°F to 46°F and using within 28 days after first puncture.
Factors influencing your compounded tirzepatide dosage
- Treatment goal: Weight loss vs. type 2 diabetes (higher doses often needed for A1c reduction).
- Side effect tolerance: Nausea, reflux, or fatigue may require slower escalation or lower maintenance dose.
- Concurrent medications: Sulfonylureas or insulin increase hypoglycemia risk; dose adjustments may be required.
- Compounding pharmacy source: 503A vs. 503B facilities influence sterility, concentration reliability; always verify COA.
- Body weight response: Non-responders after 12 weeks at 10 mg may benefit from escalating to 12.5–15 mg under medical guidance.
Quick tip: weekly dose timeline for compound users
Inject same day each week (e.g., Monday morning). If you need to change day, allow at least 3 days between doses. Compounded tirzepatide half-life is ~5 days, steady state reached after 4 weeks. Avoid dose skipping; our calculator includes standard titration to keep you on track for 2026 obesity/ metabolic health guidelines.
Safety checklist before using compounded tirzepatide
Related health tools
Frequently asked questions — compounded tirzepatide
Most clinicians recommend 2.5 mg once weekly for the first 4 weeks to minimize GI side effects. After 4 weeks, escalate to 5 mg weekly if tolerated.
Units = (Dose in mg ÷ Concentration in mg/mL) × 100. Example: 2.5 mg from a 5 mg/mL vial = (2.5/5)*100 = 50 units.
No, compounded versions are not FDA-approved brand drugs; they are custom-made by pharmacies. They contain the same active ingredient but lack regulatory oversight. Always consult a doctor.
The maximum FDA-approved maintenance dose for weight loss and T2D is 15 mg once weekly. Compounded dosing should not exceed 15 mg without specialist supervision.
This tool is designed for clinical compounding guidance under a prescription. It should not be used for non-medical or research purposes.
If you miss a dose for more than 4 days, skip the missed dose and resume your regular schedule. Never double up. Consult your provider for prolonged gaps.
Most insurance plans do not cover compounded medications. Check with your plan; some may reimburse with a valid prescription.
Important medical disclaimer
TotalCalcHub provides the compounded tirzepatide dosage calculator for educational and estimation purposes only. This does not replace professional medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved; always use under the supervision of a licensed healthcare provider. Individual responses vary. Verify your dose with your compounding pharmacist and physician. By using this tool, you agree that TotalCalcHub holds no liability for medication errors.
🇺🇸 For US patients: The information aligns with 2026 clinical guidelines but does not constitute a prescription. In case of emergency or severe side effects, contact your provider immediately.